Meet the Annual Meeting Committee

 

 


Brian Funaki, M.D., FSIR
Chair, 2018 Annual Meeting Program

An internationally recognized expert in vascular and interventional radiology, Brian Funaki, M.D., FSIR, is professor of radiology and section chief, vascular and interventional radiology at the University of Chicago Medicine where he performs the full range of vascular and non-vascular interventions, including angioplasty, stenting, thrombolysis and embolization, as well as transplant-related procedures.

Funaki has previously served on SIR’s executive council. He has authored two books and 11 book chapters. He is an associate editor of SIR’s flagship publication, the Journal of Vascular and Interventional Radiology and has served as editor-in-chief for Seminars in Interventional Radiology from 2004-2011.

 

Daniel Sze, M.D., PhD, FSIR
Chair, 2018 Workshop Program

Daniel Sze, MD, PhD, FSIR, is a professor at Stanford University, where he has spent the last 19 years helping to train the future thought leaders of interventional radiology. He is a member of Stanford’s Cancer Institute, Cardiovascular Institute, Institute for Immunity, Transplantation, and Infection, Child Health Research Institute and the Bio-X and BioDesign programs.

In his role as SIR’s 2017 Annual Scientific Meeting scientific program chair, he guides the blinded peer-review process for abstract submission and selection and is responsible for arranging the abstracts selected for the meeting into an organized oral and poster presentation program.

He serves as a co-director of the SIR Y-90 meeting and a member of the SIRF Research Grants and Education division. His clinical and research interests concentrate on image-guided treatment of cancers using oncolytic viruses, radioembolization, chemoembolization and immunotherapy. He is an active contributor to the Journal of Vascular and Interventional Radiology (JVIR), an investigator on clinical trials and a consultant to start-ups and device companies.

 

Pena

Constantino Peña, M.D., FSIR
Chair, 2018 Scientific Program

Constantino S. Peña, MD, FSIR, serves as the medical director of vascular imaging at the Miami Cardiac & Vascular Institute—a Baptist Health South Florida Center of Excellence. Dr. Peña earned his B.S. and M.S. from Stanford University prior to earning his medical degree from the Yale School of Medicine. He completed his residency in diagnostic radiology in 1999 and a fellowship in vascular and interventional radiology in 2000 at the Massachusetts General Hospital in Boston. 

Dr. Peña is a clinical assistant professor of radiology at the Florida International University College of Medicine in Miami as well as an affiliate assistant professor of radiology at the University of South Florida College of Medicine in Tampa. He has served on several SIR committees including the Interventional Oncology Service Line and International Affairs Committee. Additionally, he has served as the chair of the Cardiovascular Radiology & Intervention Council of the American Heart Association (AHA) and has served on the Radiology Information Committees of the ACR and RSNA. He enjoys reviewing for various peer-reviewed scientific journals including JVIR, CVIR, AJR, JVM and JCCT.

 


Robert J. Lewandowski, M.D., FSIR
Chair, 2017 Annual Meeting Program

Robert J. Lewandowski, M.D., FSIR, is an associate professor in radiology and director of interventional oncology at Northwestern University’s Robert H. Lurie Comprehensive Cancer Center in Chicago.

An SIR member since 2003, Lewandowski is the chair of the Interventional Oncology Service Line, and he has been involved with SIR’s Y90 course since its inception in 2011; serving as the course’s program coordinator in 2013 and 2014.

His primary interest is using loco-regional therapies to treat primary and secondary hepatic malignancies; he is involved with both pre-clinical and clinical studies in the field of interventional oncology. He has authored or co-authored numerous articles for peer-reviewed journals on topics such as chemoembolization and radioembolization to treat liver cancer.